Trial intelligence / Profile preview

Amlodipine vs Nifedipine GITS in Hypertension

NCT01030081Phase 4Completed

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Oct 2009
Primary completion
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of amlodipine in hypertension (HTN) (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Change from baseline in mean systolic blood pressure during morning hours (4 am to 8 am) at 8 weeks. Started Oct 2009; status: completed.

02

Drugs

amlodipine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01030081.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01030081.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call